BY CHRISTIAN BUNDGAARD
-
Zealand Pharma enters obesity collaboration with Roche and gets USD 1.4bn in cash
The contract concerns the excessive weight prospect petrilintide.
-
Johnson & Johnson stops depression drug development
In spite of the stop, Johnson & Johnson still means to come to be the leading neuroscience firm worldwide.
-
Venture capital firm raises EUR 1.2bn for life science investments
The resources will certainly be dispersed in brand-new funds.
-
Judge orders Dr. Huang’s KBP to reveal assets globally in Novo Nordisk lawsuit
The Singapore judgment orders Dr. Huang to divulge all his properties, which have actually currently been iced up.
-
Novo Nordisk enters collaboration with US biotech company
The Danish pharmaceutical firm can at some point come to be co-owner of Gensaic, an AI biotech firm based in Boston, Massachusetts.
-
Bavarian Nordic reports decline in operating profit and bottom line in 2024
Profits was currently understood before the magazine of the yearly record on Wednesday early morning.
-
Why one exec thinks 2025 could be Pinterest’s most pivotal year yet
Pinterest’s vp of efficiency Matt Crystal overtook Digiday to review the system’s 2025 strategies …Read More
-
Bavarian Nordic CEO awarded significant pay bump in 2024
Along with the fastened wage bundle, Paul Chaplin obtained a money retention bonus in 2024. The board is anxious concerning the low salaries in comparison with different high execu…
-
Bavarian Nordic aims to sell US priority review voucher for at least USD 150m
The Danish vaccination manufacturer remains in an excellent monetary setting and is therefore in no rush to offer its recently won coupon.
-
Bavarian Nordic adds two new candidates to pipeline after years of preclinical trials
Both prospects will certainly target locations where there are presently no authorized vaccinations, claims Bavarian Nordic CFO Henrik Juuel.
